Cargando…
Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis
BACKGROUND: Tumour regression observed in many conditional mouse models following oncogene inactivation provides the impetus to develop, and a platform to preclinically evaluate, novel therapeutics to inactivate specific oncogenes. Inactivating single oncogenes, such as c-Myc, can reverse even advan...
Autores principales: | Pelengaris, Stella, Abouna, Sylvie, Cheung, Linda, Ifandi, Vasiliki, Zervou, Sevasti, Khan, Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544575/ https://www.ncbi.nlm.nih.gov/pubmed/15613240 http://dx.doi.org/10.1186/1741-7007-2-26 |
Ejemplares similares
-
Deciphering c-MYC-regulated genes in two distinct tissues
por: Robson, Samuel C, et al.
Publicado: (2011) -
A Selective Small‐Molecule c‐Myc Degrader Potently Regresses Lethal c‐Myc Overexpressing Tumors
por: Xu, Ying, et al.
Publicado: (2022) -
C-myc and N-myc in the developing brain
por: Wey, Alice, et al.
Publicado: (2010) -
Alternative c-MYC mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors
por: Ibrahim, Dina, et al.
Publicado: (2022) -
Humanized c-Myc Mouse
por: Lehmann, Frank M., et al.
Publicado: (2012)